Glycaemic control
Glucose-dependent insulin secretion and glucose tolerance in preclinical models.
Metabolic
Metabolic · research compound
Tirzepatide
Dual GIP / GLP-1 receptor agonist · twincretin · dual incretin agonist
A 39-amino-acid dual incretin agonist that activates both the GIP and GLP-1 receptors, widely used in glucose-regulation and energy-balance research.
$117 / vial
Volume pricingMix any vials. Save up to 30%.
5vials15% off
6vials20% off
7+vials30% off
Any 5 vials take 15% off the whole order. Mix compounds and sizes; applied automatically at checkout.
For laboratory research use only. Not for human or veterinary use.
What is Tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide that acts as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. A C20 fatty diacid side chain lets it bind albumin, giving it a long half-life that suits extended study designs.
Because it engages two incretin pathways from one molecule, tirzepatide is used to study glycaemic control, insulin secretion, food intake and adipose tissue biology, and as a dual-agonist reference point alongside mono-agonists and triple agonists such as GLP-3RT.
Read the full research overview: how it works, studies and references →
Research applications
Where Tirzepatide appears in laboratory and preclinical research.
Energy intake
Appetite, food intake and body-weight endpoints in animal studies.
Incretin biology
How combined GIP and GLP-1 receptor signalling differs from either alone.
Adipose tissue
Fat-tissue metabolism and lipid handling under dual incretin agonism.
Specifications
| Product | Tirzepatide |
|---|---|
| Also known as | Dual GIP / GLP-1 receptor agonist · twincretin · dual incretin agonist |
| Class | Synthetic peptide, dual GIP / GLP-1 receptor agonist |
| Form | Lyophilized (freeze-dried) powder |
| Fill sizes | 30mg |
| Purity | 99%+, verified by HPLC for every lot |
| Storage | Lyophilized: −4 °F, protected from light. Reconstituted: 36–46 °F. |
| Documentation | Certificate of analysis for lot VD-TZ30-2610: report VPL-261008-1139 ↗. Every published certificate is on our lab reports page. Lot number supplied in writing with every order |
| Intended use | Laboratory research only. Not for human or veterinary use. |
Tirzepatide FAQ
What is tirzepatide?
Tirzepatide is a synthetic dual GIP / GLP-1 receptor agonist peptide used in laboratory research on glucose regulation and energy balance.
What does "dual agonist" mean?
It activates two receptors, here the GIP and GLP-1 receptors, rather than one. Researchers use it to study how the two incretin pathways work together.
Is Tirzepatide for human use?
No. Tirzepatide is sold strictly for laboratory research use. It is not a drug, food or supplement, and is not for human or veterinary use or for diagnosing, treating or preventing any condition.
Related compounds
View the full catalog →
Research use only. All Vivid DNA products are sold strictly for laboratory research. They are not drugs, foods, cosmetics or supplements, are not for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any disease. Statements on this page describe published and preclinical research and have not been evaluated by the Food and Drug Administration.